The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer, offering a promising new treatment approach.
Researchers at the University of Glasgow have developed the first bioengineered human bone-marrow model to test CAR T-cell therapies for acute myeloid leukaemia, offering a more accurate, non-animal testing platform.
The University of Oxford is part of a £15.9 million UK-wide programme to develop human tumour tissue models, improving cancer research, accelerating drug discovery and reducing reliance on animal testing.
The UK Radon Association is urgently calling on the Government to launch a national campaign addressing exposure to radon gas, an invisible, cancer-causing threat responsible for thousands of preventable lung cancer cases across the UK.
Researchers at King’s College London have developed a novel daily pill, KCL‑HO‑1i, that turns off tumour‑guarding macrophages and boosts chemotherapy effectiveness.
Scientists using TwinsUK data and ultra‑precise DNA sequencing have uncovered rare mutations in healthy tissue that could help explain how cancer develops early in life.
The NHS is trialling an AI-powered “one-day diagnostics” pathway for prostate cancer across up to 15 hospitals, aiming to slash diagnostic waiting times by weeks.
As Breast Cancer Awareness Month continues to gain attention across Europe, new initiatives are underway to strengthen early detection, empower women at risk, and improve the integration of cancer data.
A spider-inspired, magnetically controlled soft robot can navigate the digestive tract to deliver targeted therapy, offering a minimally invasive solution for GI diseases.
A €28 million programme brings together universities, charities and industry to advance precision oncology in Ireland and develop tailored cancer diagnostics and treatments.
UCL-led trial shows adding niraparib to standard therapy reduces tumour growth risk in men with advanced prostate cancer by up to 37%, with greater effect in specific genetic subgroups.
Childhood cancer cases are increasing across the European Union, with newly released data from the European Cancer Information System (ECIS) showing a clear upward trend in diagnoses.
Each September, Childhood Cancer Awareness Month brings attention to the fight against pediatric cancers. One of the promising projects currently making waves in this field is MONALISA, a Horizon Europe-funded initiative under the EU Cancer Mission.
